Genetic variants in membranous nephropathy: Perhaps a perfect storm rather than a straightforward conformeropathy?

Journal of the American Society of Nephrology

Volumn 24, Issue 4, 2013, Pages 525-528

  Salant, David J ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; PHOSPHOLIPASE A2 RECEPTOR;

EDITORIAL; EXON; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; PLA2R GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875700090     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013020166     Document Type: Editorial

References (22)

1. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11-21, 2009
2. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Antiphospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
3. Vaughan RW, Demaine AG, Welsh KI: A DQA1 allele is strongly associated with idiopathic membranous nephropathy. Tissue Antigens 34: 261-269, 1989
4. Klouda PT, Manos J, Acheson EJ, Dyer PA, Goldby FS, Harris R, Lawler W, Mallick NP, Williams G: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2: 770-771, 1979
5. Ogahara S, Naito S, Abe K, Michinaga I, Arakawa K: Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int 41: 175-182, 1992
6. Chevrier D, Giral M, Perrichot R, Latinne D, Coville P, Muller JY, Soulillou JP, Bignon JD: Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci. Tissue Antigens 50: 164-169, 1997
7. Le Petit JC, Laurent B, Berthoux FC: HLA-DR3 and idiopathic membranous nephritis (IMN) association. Tissue Antigens 20: 227-228, 1982
8. Kim S, Chin HJ, Na KY, Kim S, Oh J, Chung W, Noh JW, Lee YK, Cho JT, Lee EK, Chae DW; Progressive Renal Disease and Medical Informatics and Genomics Research (PREMIER) members: Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract 117: c253-c258, 2011
9. Liu YH, Chen CH, Chen SY, Lin YJ, Liao WL, Tsai CH, Wan L, Tsai FJ: Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan. J Biomed Sci 17: 81, 2010
10. Llorca O: Extended and bent conformations of the mannose receptor family. Cell Mol Life Sci 65: 1302-1310, 2008
11. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616-626, 2011
12. Coenen MJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B, Boland-Augé A, Groothuismink JM, Bockenhauer D, Powis SH, Mathieson PW, Brenchley PE, Kleta R, Wetzels JFM, Ronco P: Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 24: 677-683, 2013
13. Costantini S, Rossi M, Colonna G, Facchiano AM: Modelling of HLADQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease. J Mol Graph Model 23: 419-431, 2005
14. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, NikamM, Poulton K,McWilliam L, Short CD, Venning M, Brenchley PE: Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy [published online head of print January 30, 2013]. Kidney Int doi: 10.1038/ki.2012.486
15. Segelmark M: Genes that link nephritis to autoantibodies and innate immunity. N Engl J Med 364: 679-680, 2011
16. van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, den Bleker TH, Wiegman L, Vink T, Aarden LA, De Baets MH, van de Winkel JG, Aalberse RC, Parren PW: Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317: 1554-1557, 2007
17. Jennette JC, Hipp CG: Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83: 415-420, 1985
18. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, Aljama-García P: C4d as a diagnostic tool in membranous nephropathy. Nefrologia 32: 295-299, 2012
19. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, Iwasaki H: IgG subclasses and complement pathway in segmental and globalmembranous nephropathy. Pediatr Nephrol 25: 1091-1099, 2010
20. Ma H, Beck LH Jr, Salant DJ: Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway. J Am Soc Nephrol 22: 62A, 2011
21. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1: 237-243, 1995
22. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzic I, Campbell H, Wright A, Hastie ND,Wilson JF, Rudan I,WuhrerM, Rudd PM, Josic D, Lauc G: High throughput isolation and glycosylation analysis of IgGvariability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10: M111.010090, 2011